X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-withdraws-approval-covis-pharmas-preterm-birth-prevention-drug-2023-04-06/
https://www.biopharmadive.com/news/fda-makena-withdrawal-preterm-birth-drug-covis/644418/
https://www.fiercepharma.com/pharma/covis-granted-fda-hearing-latest-twist-over-controversial-premature-birth-med-makena
https://www.raps.org/news-and-articles/news-articles/2021/3/fda-unmoved-by-new-meta-analysis-still-recommends
https://www.globenewswire.com/news-release/2020/10/14/2108720/0/en/AMAG-Pharmaceuticals-Requests-Hearing-to-Maintain-Makena-Hydroxyprogesterone-Caproate-Injection-as-a-Treatment-Option-for-Clinically-Indicated-Pregnant-Patients.html
https://www.raps.org/news-and-articles/news-articles/2020/10/fda-seeks-withdrawal-of-makena-generics-from-marke#:~:text=The%20US%20Food%20and%20Drug,failed%20to%20confirm%20clinical%20benefit
http://www.pharmafile.com/news/560651/covis-group-acquire-amag-pharmaceuticals-647m-deal
http://www.pharmafile.com/news/560651/covis-group-acquire-amag-pharmaceuticals-647m-deal
https://www.raps.org/news-and-articles/news-articles/2020/10/fda-seeks-withdrawal-of-makena-generics-from-marke
https://www.raps.org/news-and-articles/news-articles/2019/10/makena-withdrawal-a-look-at-the-timeline-and-othe
https://www.biopharmadive.com/news/amag-makena-fda-advisory-panel-vote-withdrawal-preterm-birth/566159/
https://seekingalpha.com/news/3510592-amag-pharma-shares-halted-pending-outcome-ad-com-meeting
https://www.biospace.com/article/releases/amag-pharmaceuticals-stock-trading-halted-today-fda-advisory-committee-meeting-to-discuss-the-results-of-the-makena-prolong-trial/?s=95
https://www.fiercepharma.com/pharma/fda-review-troubled-drug-could-hobble-amag-proxy-fight-activist-investor
https://endpts.com/embattled-amag-braces-for-october-fda-makena-adcom-but-it-need-not-worry-analyst/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210724
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211777
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211142
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211070
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2019-1555476880.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208381
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210877
https://www.prnewswire.com/news-releases/uspto-grants-priority-motion-to-lipocine-and-enters-judgment-against-clarus-300776981.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-9-2019-1547012578.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210618
https://www.pharmacompass.com/pdf/news/inventive-infusion-solutions-receives-fda-form-483-1538036934.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210723
http://www.pharmafile.com/news/513573/fda-approved-preterm-birth-drug-has-no-benefit-and-may-cause-harm-study-suggests
http://www.biospace.com/News/why-price-gouging-may-come-to-an-end/400448/source=TopBreaking
http://www.reuters.com/article/2015/11/18/us-amag-fda-idUSKCN0T738020151118#Pe3qBimVm2EHslCR.97
http://www.prnewswire.com/news-releases/mcguff-pharmaceuticals-inc-announces-fda-approval-for-hydroxyprogesterone-caproate-injection-usp-hpc-300154280.html
http://www.biospace.com/News/fda-seeks-more-info-before-approving-amag/378826/source=MoreNews
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1098-2015&w=06032015&lang=eng
Market Place
Share 
